P

Philogen
PHIL

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€866.23M
EV
€815.53M
Shares Outstanding
40.29M
Beta
0.11

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€26.00
P/E 2025E
9.77x
P/Revenue 2025E
5.09x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Philogen S.p.A.

gainify

P

Philogen S.p.A.

PHIL

Philogen S.p.A., a biotechnology company, develops drugs for oncology and chronic inflammatory diseases. It is developing Nidlegy, a combination of the immunocytokines L19IL2 and L19TNF developed intralesional treatment for locoregional melanoma and non-melanoma skin ...

Sector

Healthcare

Industry

Biotechnology

CEO

Neri, Dario

Employees

174

IPO Date

2021-03-03

Headquarters

Piazza La Lizza #7, Siena, Siena, 53100, Italy

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved